President Biden announced a National Month of Action to enable 70 percent of U.S. adults to get at least one COVID-19 vaccine shot before July 4. To date, 63 percent of U.S. adults have been vaccinated.
Among initiatives during the National Month of Action, KinderCare and LearningCare, along with more than 500 YMCA facilities across the country, will offer no-cost, drop-in child care for parents or guardians who are getting vaccinated or recovering from vaccination. The Department of Health and Human Services also issued new guidance directing states to use American Rescue Plan funding to encourage neighborhood- and home-based child care providers to offer similar support.
Additionally, four pharmacy chains — Albertsons, CVS, Rite-Aid, and Walgreens — will have extended hours every Friday in June.
The administration also will partner with the Black Coalition Against COVID, the University of Maryland Center for Health Equity, and SheaMoisture on “Shots at the Shop,” a vaccine education and outreach initiative at Black-owned barbershops and beauty salons nationwide.
Other efforts under the National Month of Action include community canvassing, phone banking, text banking, a challenge to mayors to grow citywide vaccination rates, a COVID-19 college challenge, and a National Association of Broadcasters campaign. Vice President Kamala Harris will embark on a nationwide “We Can Do This” tour beginning in the South.
Moderna Submits Biologics License Application
Moderna announced June 1 it began the rolling submission process for a biologics license application with the Food and Drug Administration (FDA) for its COVID-19 vaccine. Moderna has requested a priority review and will continue submitting phase 3 trial data to the agency as it is available.
CDC Adds Health Equity Page to COVID-19 Data Tracker
The Centers for Disease Control and Prevention (CDC) June 3 added a new health equity landing page on its COVID-19 data tracker. This page aggregates data on:
- racial and ethnic minority populations;
- people living in rural or frontier areas;
- people experiencing homelessness;
- essential and front-line workers;
- people with disabilities;
- people with substance use disorders;
- people involved in the justice system; and
- people born outside of the United States.
FDA Recalls COVID-19 Test
FDA on June 1 issued a class I recall for the unauthorized Lepu Medical Technology SARS-CoV-2 Antigen Rapid Test Kit and the Leccurate SARS-CoV-2 Antibody Rapid Test Kit (Colloidal Gold Immunochromatography). These tests, which were distributed to pharmacies to be sold for at-home testing by consumers and sold directly to consumers, have high rates of false results.
Visit the America’s Essential Hospitals coronavirus resource page for more information about the pandemic.
Contact Senior Director of Policy Erin O’Malley at email@example.com or 202.585.0127 with questions.